Page 9 - Under Its News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(1) Lexaria Recently Announced Favorable Data on Its First Animal Study, As Well as the Commencement of Its First Human Clinical Study, Under Its 2021 Hypertension R&D Program KELOWNA, BC / ACCESSWIRE / May 7, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the Company or Lexaria ), a global innovator in drug delivery platforms, today announced that CEO Chris Bunka is presenting at the Benzinga Global Small Cap Conference to be held on May 13-14, 2021. Complimentary investor registration can be accessed through the conference link below. Presentation date: Thursday, May 13, 2021 Presentation time: 3:50 p.m. ET / 12:50 p.m. PT Event registration link: Benzinga Global Small Cap Conference

Chris bunkaExchange commissionHypertension rd programCompany or lexariaLexaria bioscience corpDrug administrationLexaria recently announced favorable dataIts first animal studyIts first human clinical studyUnder itsLexaria bioscienceBenzinga global small cap conferenceBenzinga global small capகிறிஸ் பங்காபரிமாற்றம் தரகுகீழ் அதன்